to make the first generic version of the widely used blood thinner Lovenox. The approval positions Momenta and Sandoz to offer a cheaper but still lucrative alternative to Lovenox, which had sales ...

WASHINGTON—The Food and Drug Administration approved the first generic version of the big-selling blood thinner Lovenox, hitting Sanofi-Aventis SA and bringing a victory to Novartis AG's ...

Sanofi-Aventis has gone to court here in Washington to prevent rival drugmaker Novartis from selling a generic version of the blockbuster blood-thinner Lovenox. What's the problem? Well ...

Sandoz, the generics division of Novartis, is soliciting pre-orders for Sanofi-Aventis blood thinner Lovenox—actions that seem to suggest generic approval of the megablockbuster may be coming soon, ...

Bridgewater, NJ - The FDA has approved a supplemental new drug application (sNDA) regarding the use of enoxaparin (Lovenox ®, Aventis) antithrombotic therapy in patients with mechanical ...

and partner Momenta Pharmaceuticals Inc. of Boston won Food and Drug Administration approval last Friday for a generic version of Lovenox.

In an earlier version of this article, we inaccurately described the change to the Lovenox (enoxaparin) prescribing information. The revisions to the prescribing information regarding prosthetic ...

The FDA approved generic enoxaparin sodium, a version of Sanofi’s Lovenox, developed under a collaboration between Momenta Pharmaceuticals and Sandoz, the generics division of Swiss drug maker ...